Liang Ma
-
- Natural Compounds in Disease Treatment 5
- Toxicology top 5%
-
- Biological Activity of Diterpenoids and Biflavonoids 5
- Cancer-related gene regulation 4
- Bioactive Natural Diterpenoids Research 3
- Natural product bioactivities and synthesis 3
- Cell death mechanisms and regulation 3
- Ubiquitin and proteasome pathways 3
-
- Autophagy in Disease and Therapy 4
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Liang Ma
50 papers receiving 955 citations
Peers
Comparison fields: 5 of 98
- Complementary and alternative medicine 150
- Toxicology 61
- Cancer Research 122
- Molecular Biology 532
- Oncology 195
Countries citing papers authored by Liang Ma
This map shows the geographic impact of Liang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Ma more than expected).
Fields of papers citing papers by Liang Ma
This network shows the impact of papers produced by Liang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Ma. The network helps show where Liang Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 38 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 20 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 16 | |
| 15 | 2017 | 14 | |
| 16 | 2017 | 9 | |
| 17 | 2015 | 76 | |
| 18 | 2014 | 44 | |
| 19 | 2014 | 12 | |
| 20 | 2012 | 78 |
About Liang Ma
Liang Ma is a scholar working on Complementary and alternative medicine, Toxicology and Molecular Biology, having authored 52 papers that have together received 969 indexed citations. Recurring topics across this work include Biological Activity of Diterpenoids and Biflavonoids (5 papers), Natural Compounds in Disease Treatment (5 papers), Cancer-related gene regulation (4 papers), Autophagy in Disease and Therapy (4 papers), Bioactive Natural Diterpenoids Research (3 papers), Natural product bioactivities and synthesis (3 papers), Cell death mechanisms and regulation (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Complementary and alternative medicine (150 citations), Toxicology (61 citations) and Cancer Research (122 citations). Liang Ma has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Guang‐Biao Zhou, Zi Liu, Zhesheng Wen, Zheng Hu, Peng Teng, Yiming Ni, Hongfei Xu, Weidong Li, Xianjun Yu and Jin Gao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.